CN105746728A - Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder - Google Patents
Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder Download PDFInfo
- Publication number
- CN105746728A CN105746728A CN201610143847.4A CN201610143847A CN105746728A CN 105746728 A CN105746728 A CN 105746728A CN 201610143847 A CN201610143847 A CN 201610143847A CN 105746728 A CN105746728 A CN 105746728A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- powder
- milk powder
- acid
- premix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
- A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/04—Whey; Whey preparations containing non-milk components as source of fats or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/10—Whey; Whey preparations containing inorganic additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses infant formula milk powder simulating breast milk and a preparation method of the infant formula milk powder.The infant formula milk powder is prepared from, by weight percentage, base powder, galactooligosaccharide, fructo-oligosaccharide, L-carnitine, inositol, probiotic, docosahexaenoic acid, eicostatetraenoic acid, nucleotide, lutein, taurine and choline.Fatty acid in the infant formula milk powder is formed by mixing and proportioning five plant oils, and 1, 3 dioleic acid 2-palmitic acid triglyceride (OPO structure lipid) is added.The infant formula milk powder is conducive to absorption of fatty acid and calcium, can promote infant skeleton health, can effectively reduce calcium soap constipation caused by palmitic acidin conventional formula milk powder, can soften excrement of infants and is easier for the infants to digest and absorb.
Description
Technical field
The present invention relates to food compositions processing technique field, particularly relate to a kind of infant formula milk simulating breast milk
Powder and preparation method thereof.
Background technology
Breast milk is infant optimal natural nutrition source, can not carry out breast feeding yet with individual's reason
, baby formula milk powder is then preferable breast milk succedaneum.Therefore breast milk is also baby formula milk powder research and development
Golden standard, breast milk nutrition is also constantly studied by scientist, promote baby formula milk powder development.
The nutrient categories the most contained by adding breast milk at present simulates breast milk nutrition, as protein, fat,
As far as possible close to breast milk in the nutrient categories such as carbohydrate, mineral, vitamin and quantity.
Along with the development of science and technology, research is constantly found that other nutrient of breast milk, as probiotic bacteria, 1,3
Two oleic acid 2-palmitic acid three esters etc., Structure grease spy contain 1,3-bis-oleic acid ,-2-palmitic acid three
Ester be in breast milk Palmic acid be primarily present form.Research shows, the satisfied fatty acid that in breast milk, content is the highest is
Palmic acid, accounts for the 17-25% of ripe breast milk fatty acids, wherein has the Palmic acid of about 70% to be distributed in Sn-2 position
On, in breast milk, a kind of main triglyceride is 1,3-bis-oleic acid ,-2-palmitic acid three ester.Structure grease from
Fatty acid structure simulates Palmic acid structure composition in breast milk in form.Be conducive to fatty acid and calcareous absorption, and
Promote infant bone health, the calcium soap constipation problem that in conventional formulation milk powder, Palmic acid causes can be eliminated.Research
Show that breast milk nutrient is a complicated trophosome, in macroscopic view nutrient categories and quantity, only simulate breast milk
Not enough, Nutrients Absorption and the functional development of baby be there is also important by ratio and the microstructure of its nutrient
Relation.
Summary of the invention
The present invention solves the problems referred to above of the prior art, it is provided that a kind of infant formula milk simulating breast milk
Powder, inventive formulation Fatty Acids In Milk Powder forms through 5 vegetable oil mixing match, its fatty acid composition after proportioning
Form closer to breast milk fatty acids, add OPO structured lipid (OPO) fat
Fat acid structural simulation breast milk fatty acids structure, carbohydrate is full milk sugar, and 2 kinds can effectively facilitate intestinal
The propagation of the multiple bacillus bifidus in road, and suppress harmful bacteria and the prebiotic, fructooligosaccharide, oligomeric of amphimicrobe propagation
Galactose, simultaneously regulation lactalbumin and casein ratio, for all ages and classes 0-6 month baby milk albumin:
Casein >=6:4, more than 6 months bigger infants and young's lactalbumins: casein >=1:1, make protein ratio and
Aminoacid forms closer to breast milk.Can effectively reduce infant to get angry and constipation, support infant intestinal
Group's stability, it is easier to digest and assimilate, reduces metabolism burden.
Present invention also offers the preparation method of a kind of baby formula milk powder simulating breast milk, by controlling product
The technology such as middle water activity and packaging remaining oxygen, at utmost preserve the baby formula milk powder of probiotic active,
Avoid probiotic bacteria and producing the activity decay in a large number of storage process, extend the shelf life of product；Probiotic bacteria warp
After crossing special embedding treatment, can still retain higher survival rate after by gastric juice and bile and intestinal mucosa adheres to
Ability；Probiotic bacteria adds employing two-stage mixing, dry process, it is ensured that mixing homogeneity.
For achieving the above object, the present invention is by the following technical solutions:
The first aspect of the invention is to provide a kind of baby formula milk powder simulating breast milk, by weight percentage
Meter, formulated by following raw material components: skimmed milk powder 10～40%, desalted whey powder 25～45%, to concentrate
Lactalbumin powder 1.0～8.0%, 1,3-bis-oleic acid 2-palmitic acid three ester (OPO structured lipid) 5～20%,
Vegetable oil 5～20%, lactose 5～20%, phosphatidase 0～0.5%, calcium carbonate 0.01～0.5%, compounding mineral
Premix material 0.05～0.95%, compounding vitamin premix 0.01～0.12%, oligomeric galactose 0.1～5.0%,
Oligofructose 0.1～5.0%, animal bifidobacteria (Bb-12) 0～0.1%, Bifidobacterium lactis (Bi-07) 0～
0.1%, docosahexenoic acid 0～0.14%, eicosatetraenoic acid 0～0.18%, choline 0～0.05%, core
Thuja acid 0～0.06%, phylloxanthin 0～0.0004%, L-carnitine 0.01～0.1%, taurine 0～0.07%,
Inositol 0.01～0.2%, L-AA sodium 0.03～0.12%；
Described compounding mineral substance premix by mass percentage, including following raw material components: potassium chloride 5～
33%, sodium chloride 6～18%, copper sulfate 0.01～0.50%, magnesium sulfate 5～15%, ferrous sulfate 10～45%,
Zinc sulfate 0.5～8.0%, manganese sulfate 0.1～1.0%, sodium selenite 0.1～5.0%, sodium citrate 10～21%,
Lactose 10～25%；
Described compounding vitamin premix by mass percentage, including following raw material components: retinol acetate (dimension
Raw element A) 5～18%, cholecalciferol (vitamin D3) 3～12%, dl-α-tocopheryl acetate (vitamin E)
27～40%, phytonadione (vitamin K) 0.5～5.0%, thiamine nitrate (vitamin B1) 0.5～
4.0%, riboflavin (vitamin B2) 0.05～3.00%, pyridoxine hydrochloride (vitamin B6) 0.5～3.0%,
Cobalamin (vitamin B12) 0.5～5.0%, nicotiamide 4～12%, folic acid 0.5～5.0%, D-VB5 calcium
0.5～5.0%, biotin 0.5～5.0%, potassium iodide 0.5～5.0%, lactose 15～30%；
Described animal bifidobacteria (Bb-12) specification is 30IF (30 × 108Cfu/g), Bifidobacterium lactis (Bi-07)
Specification is 300B (300 × 108Cfu/g), described animal bifidobacteria (Bb-12) and Bifidobacterium lactis (Bi-07)
Interpolation total amount be 0.5 × 107～3 × 107cfu/g。
Further, by weight percentage, the raw material components of inventive formulation milk powder also includes lactoferrin
0.001～0.05%, sialic acid 0.002～0.007%.
Further, described compounding mineral substance premix also includes calcium hydrogen phosphate 0.1～1.0%, calcium pyrophosphate
0.5～2.0%.
Further, by weight percentage, the raw material components of inventive formulation milk powder also includes medium chain triglyceride
The use of three esters, described medium chain triglyceride and OPO (OPO structured lipid)
Amount ratio is 1:4～1:6.
Further, by weight percentage, formulated by following raw material components: skimmed milk powder 15～35%,
Desalted whey powder 30～45%, concentrated whey protein powder 1.0～5.0%, 1,3-bis-oleic acid 2-palmitic acid three
Ester (OPO structured lipid) 7～13%, vegetable oil 8～15%, lactose 8～15%, phosphatidase 0 .2～0.4%,
Calcium carbonate 0.1～0.35%, compounding mineral substance premix 0.1～0.8%, compounding vitamin premix 0.05～
0.10%, oligomeric galactose 0.5～2%, oligofructose 0.2～2%, animal bifidobacteria (Bb-12) 0.001～
0.05%, Bifidobacterium lactis (Bi-07) 0.001～0.05%, docosahexenoic acid 0.01～0.1%, 20
Carbon tetraenoic acid 0.05～0.1%, choline 0.02～0.04%, nucleotide 0～0.03%, phylloxanthin 0.0001～
0.0003%, L-carnitine 0～0.02%, taurine 0.01～0.04%, inositol 0～0.1%, L-Vitamin C
Acid sodium 0.04～0.11%.
Further, by weight percentage, formulated by following raw material components: skimmed milk powder 18%, de-
Salt whey powder 40%, concentrated whey protein powder 1.5%, vegetable oil 14%, 1,3-bis-oleic acid 2-palmitic acid three
Ester (OPO structured lipid) 12%, lactose 11.7568%, phosphatidase 0 .15%, calcium carbonate 0.3%, compounding mineral
Premix material 0.7%, compounding vitamin premix 0.07%, oligomeric galactose 0.8%, oligofructose 0.4%, dynamic
Thing bacillus bifidus (Bb-12) 0.003%, Bifidobacterium lactis (Bi-07) 0.005%, docosahexenoic acid
0.03%, eicosatetraenoic acid 0.06%, choline 0.06%, inositol 0.03%, nucleotide 0.03%, phylloxanthin
0.0002%, L-carnitine 0.01%, taurine 0.035%, L-AA sodium 0.06%.
Further, by mass percentage, described compounding mineral substance premix includes following raw material components: chlorine
Change potassium 26%, sodium chloride 12.5%, copper sulfate 0.12%, magnesium sulfate 10.5%, ferrous sulfate 13.5%, sulfur
Acid zinc 1.78%, manganese sulfate 0.15%, sodium selenite 0.55%, sodium citrate 14.4%, lactose 19.5%.
Further, by mass percentage, described compounding vitamin premix includes following raw material components: vinegar
Acid retinyl ester (vitamin A) 9.8%, cholecalciferol (vitamin D3) 6.5%, dl-α-tocopheryl acetate (dimension
Raw element E) 34.5%, phytonadione (vitamin K) 2.2%, thiamine nitrate (vitamin B1) 0.95%,
Riboflavin (vitamin B2) 0.23%, pyridoxine hydrochloride (vitamin B6) 0.91%, cobalamin (vitamin
B12) 2.91%, nicotiamide 8.0%, folic acid 2.2%, D-VB5 calcium 2.7%, biotin 2.8%, potassium iodide
2.0%, lactose 24.3%.
Described vegetable oil is mixed vegetable oil and OPO Structure grease mixes according to 1.2:1 ratio.
Wherein, described mixed vegetable oil is soybean oil, high oleic sunflower oil, Semen Maydis oil, Petiolus Trachycarpi oil and Cortex cocois radicis
Oil is by weight 1:(0.5-1.2): (1-1.6): (0.3-0.8): (1.5-2.3) mixes.
Further, described vegetable oil is soybean oil, high oleic sunflower oil, Semen Maydis oil, Petiolus Trachycarpi oil and Cortex cocois radicis
Oil is by weight 1:(0.6-1.2): (1-1.5): (0.4-0.7): (1.6-2.2) mixes.
Further, mixed vegetable oil is by soybean oil, high oleic sunflower oil, Semen Maydis oil, Petiolus Trachycarpi oil and Cortex cocois radicis
Oil is by weight 1:(0.7-0.9): (1-1.1): (0.5-0.6): (1.7-2) mixes.
Preferably, described vegetable oil is soybean oil, high oleic sunflower oil, Semen Maydis oil, Petiolus Trachycarpi oil and Oleum Cocois
Compound lard, by mass percentage, described soybean oil, high oleic sunflower oil, Semen Maydis oil, Petiolus Trachycarpi oil and
Oleum Cocois amount ratio is 1:0.8:1.1:0.6:1.8.
Further, described animal bifidobacteria (Bb-12) and Bifidobacterium lactis (Bi-07) interpolation total amount are
1×107cfu/g。
The second aspect of the invention, method provides the preparation side of a kind of baby formula milk powder simulating breast milk
Method, specifically includes following steps:
Step 1, one-level batch mixing: by skimmed milk powder, desalted whey powder, concentrated whey protein powder, vegetable oil,
Lactose, phospholipid and calcium carbonate use the pure water mixed dissolution of 50～70 DEG C, are sufficiently stirred for；
Step 2, two grades of batch mixings: by compounding mineral substance premix, compounding vitamin premix respectively each special
By 20 times amount 30～the dissolved in purified water of 40 DEG C in container, substep add step 1 to) batch mixing in fill
Divide mixing, compounding mineral and compounding vitamin to add incorporation time and answer >=10min；
Step 3, homogenizing: by step 2) dissolve the material mixed and carry out homogenizing, homogenization pressure be 20～
22Mpa；
Step 4, pre-sterilizing: by step 3) material after homogenizing carries out pre-sterilizing, sterilization temperature 80～90 DEG C,
Sterilizing time 16s, cools down, keeps in, temporary temperature 8～15 DEG C, temporary storage time≤4h；
Step 5, sterilization concentrates: by step 4) temporary material sends into vaporization chamber and carries out sterilization and concentrate, sterilization
Temperature 87～90 DEG C, sterilizing time 24s, an effect evaporating temperature 62～72 DEG C, two effect evaporating temperatures 46～56 DEG C,
Evaporating pressure-0.086～-0.095Mpa, sterilization pressure 0.05～0.02Mpa；Discharge concentration 16.0～21.0 ° of Be；
Step 6, be dried: by step 5) concentrate after material send into drying tower through high-pressure pump, process conditions are:
Inlet temperature 145～175 DEG C, temperature of outgoing air 65～92 DEG C, negative pressure (-0.5～-4.0) × 100pa in tower, fluidisation
Bed negative pressure: (-0.5～-3.5) × 100pa, one section of temperature 30～85 DEG C, two-stage nitration temperature 5～55 DEG C, three sections of temperature
5～35 DEG C, four sections of temperature 5～30 DEG C, high-pressure pump pressure 15～30Mpa is spray-dried；And by stream
Change bed and carry out redrying powder delivery, powder delivery temperature≤38 DEG C, moisture≤4.0%, obtain original washing powder；
Step 7, premix: by animal bifidobacteria (Bb-12), Bifidobacterium lactis (Bi-07), oligomeric half
Lactose, oligofructose, docosahexenoic acid, eicosatetraenoic acid, choline, nucleotide, phylloxanthin, a left side
Rotation carnitine, taurine, inositol, L-AA sodium premix respectively according to addition；
Step 8, mixing: by original washing powder and step 7) premix material mixes according to formula proportion, obtains finished powder.
Step 9, packaging, detection, warehouse-in.
Further, described step 2) in, when dissolving compounding mineral substance premix and compounding vitamin premix,
First dissolving compounding mineral substance premix, after 10min, re-dissolved compounds vitamin premix.
Further, described step 7) in, described animal bifidobacteria (Bb-12), Bifidobacterium lactis (Bi-07),
Oligomeric galactose, oligofructose, docosahexenoic acid, eicosatetraenoic acid, choline, nucleotide, leaf are yellow
Element, L-carnitine, taurine, inositol, L-AA sodium need, through expanding dilution, to expand dilute before premix material
Releasing use HS-10 three-dimensional motion mixer, motion frequency is 35HZ, and incorporation time is 30s.
The present invention uses technique scheme, compared with prior art, has the following technical effect that
In inventive formulation milk powder, oligofructose and oligomeric galactose are as the food of beneficial bacteria of intestinal tract, can promote intestinal benefit
The increment of raw bacterium, after with the addition of prebiotics, adds probiotic bacteria simultaneously, and infant can be helped to quickly form with benefit
Raw bacterium is the intestinal microbial population of dominant microflora, and maintains stablizing of intestinal dominant microflora, thus suppresses harmful bacteria, limit
Pathogenic microorganism processed and intestinal mucosa adhere to, field planting；Inventive formulation milk powder scalable intestinal microbial population, optimizes intestinal
Environment, forms stable intestinal dominant microflora, promotes Nutrients Absorption, promotes defecation speed, softens stool,
Constipation, prevents healthy babies from suffering from acute diarrhea.
Accompanying drawing explanation
Fig. 1 is the probiotic bacteria Bb-12 fading curve that the present invention simulates in the baby formula milk powder of breast milk.
Detailed description of the invention
The invention provides the preparation method of a kind of baby formula milk powder simulating breast milk.
Below by specific embodiment, the present invention is carried out detailed and concrete introduction, so that being better understood from this
Bright, but following embodiment is not limiting as the scope of the invention.
The baby formula milk powder of embodiment 1 preparation simulation breast milk
Including following raw material components: skimmed milk powder 18%, desalted whey powder 40%, concentrated whey protein powder 1.5%,
Vegetable oil 14%, 1,3-bis-oleic acid 2-palmitic acid three ester (OPO structured lipid) 12%, lactose 11.7568%,
Phosphatidase 0 .15%, calcium carbonate 0.3%, compounding mineral substance premix 0.7%, compounding vitamin premix 0.07%,
Oligomeric galactose 0.8%, oligofructose 0.4%, animal bifidobacteria (Bb-12) 0.003%, Bifidobacterium lactis
(Bi-07) 0.005%, docosahexenoic acid 0.03%, eicosatetraenoic acid 0.06%, choline 0.06%,
Inositol 0.03%, nucleotide 0.03%, phylloxanthin 0.0002%, L-carnitine 0.01%, taurine 0.035%,
L-AA sodium 0.06%.
Wherein, compounding mineral substance premix by mass percentage, including following raw material components: potassium chloride 26%,
Sodium chloride 12.5%, copper sulfate 0.12%, magnesium sulfate 10.5%, ferrous sulfate 13.5%, zinc sulfate 1.78%,
Manganese sulfate 0.15%, sodium selenite 0.55%, sodium citrate 14.4%, lactose 19.5%.
Compounding vitamin premix by mass percentage, including following raw material components: (dimension is raw for retinol acetate
Element A) 9.8%, cholecalciferol (vitamin D3) 6.5%, dl-α-tocopheryl acetate (vitamin E) 34.5%,
Phytonadione (vitamin K) 2.2%, thiamine nitrate (vitamin B1) 0.95%, (dimension is raw for riboflavin
Element B2) 0.23%, pyridoxine hydrochloride (vitamin B6) 0.91%, cobalamin (vitamin B12) 2.91%,
Nicotiamide 8.0%, folic acid 2.2%, D-VB5 calcium 2.7%, biotin 2.8%, potassium iodide 2.0%, lactose 24.3%.
Animal bifidobacteria (Bb-12) specification is 30IF, and Bifidobacterium lactis (Bi-07) specification is 300B,
It is 1 × 10 that probiotic bacteria animal bifidobacteria (Bb-12) and Bifidobacterium lactis (Bi-07) add total amount7cfu/g。
The preparation method of the present embodiment 1, specifically includes following steps:
Step 1, one-level batch mixing: by skimmed milk powder, desalted whey powder, concentrated whey protein powder, vegetable oil,
Lactose, phospholipid and calcium carbonate use the pure water mixed dissolution of 50～70 DEG C, are sufficiently stirred for；
Step 2, two grades of batch mixings: by compounding mineral substance premix, compounding vitamin premix respectively each special
By 20 times amount 30～the dissolved in purified water of 40 DEG C in container, substep add step 1 to) batch mixing in fill
Divide mixing, compounding mineral and compounding vitamin to add incorporation time and answer >=10min；
Step 3, homogenizing: by step 2) dissolve the material mixed and carry out homogenizing, homogenization pressure be 20～
22Mpa；
Step 4, pre-sterilizing: by step 3) material after homogenizing carries out pre-sterilizing, sterilization temperature 80～90 DEG C,
Sterilizing time 16s, cools down, keeps in, temporary temperature 8～15 DEG C, temporary storage time≤4h；
Step 5, sterilization concentrates: by step 4) temporary material sends into vaporization chamber and carries out sterilization and concentrate, sterilization
Temperature 87～90 DEG C, sterilizing time 24s, an effect evaporating temperature 62～72 DEG C, two effect evaporating temperatures 46～56 DEG C,
Evaporating pressure-0.086～-0.095Mpa, sterilization pressure 0.05～0.02Mpa；Discharge concentration 16.0～21.0 ° of Be；
Step 6, be dried: by step 5) concentrate after material send into drying tower through high-pressure pump, process conditions are:
Inlet temperature 145～175 DEG C, temperature of outgoing air 65～92 DEG C, negative pressure (-0.5～-4.0) × 100pa in tower, fluidisation
Bed negative pressure: (-0.5～-3.5) × 100pa, one section of temperature 30～85 DEG C, two-stage nitration temperature 5～55 DEG C, three sections of temperature
5～35 DEG C, four sections of temperature 5～30 DEG C, high-pressure pump pressure 15～30Mpa is spray-dried；And by stream
Change bed and carry out redrying powder delivery, powder delivery temperature≤38 DEG C, moisture≤4.0%, obtain original washing powder；
Step 7, premix: by animal bifidobacteria (Bb-12), Bifidobacterium lactis (Bi-07), oligomeric half
Lactose, oligofructose, docosahexenoic acid, eicosatetraenoic acid, choline, nucleotide, phylloxanthin, a left side
Rotation carnitine, taurine, inositol, L-AA sodium premix respectively according to addition；
Step 8, mixing: by original washing powder and step 7) premix material mixes according to formula proportion, obtains finished powder.
Step 9, packaging, detection, warehouse-in, testing result such as table 1 below.
The baby formula milk powder of embodiment 2 preparation simulation breast milk
Including following raw material components: skimmed milk powder 29%, desalted whey powder 31%, concentrated whey protein powder 3.4%,
Vegetable oil 11%, 1,3-bis-oleic acid 2-palmitic acid three ester (OPO structured lipid) 9%, lactose 14.6276%,
Phosphatidase 0 .3%, calcium carbonate 0.3%, compounding mineral substance premix 0.25%, compounding vitamin premix 0.06%,
Oligomeric galactose 0.8%, oligofructose 0.4%, animal bifidobacteria (Bb-12) 0.003%, breast bifid bar
Bacterium (Bi-07) 0.005%, docosahexenoic acid 0.03%, eicosatetraenoic acid 0.05%, choline 0.03%,
Inositol 0.03%, nucleotide 0.03%, phylloxanthin 0.0004%, L-carnitine 0.012%, taurine 0.032%,
L-AA sodium 0.04%.
Wherein, compounding mineral substance premix by mass percentage, including following raw material components: potassium chloride 7.5%,
Sodium chloride 10.5%, copper sulfate 0.33%, magnesium sulfate 6.5%, ferrous sulfate 41.3%, zinc sulfate 4.4%,
Manganese sulfate 0.32%, sodium selenite 1.6%, sodium citrate 17.3%, lactose 10.25%.
Compounding vitamin premix by mass percentage, including following raw material components: (dimension is raw for retinol acetate
Element A) 11.8%, cholecalciferol (vitamin D3) 8.4%, dl-α-tocopheryl acetate (vitamin E) 31.5%,
Phytonadione (vitamin K) 2.7%, thiamine nitrate (vitamin B1) 1.4%, (dimension is raw for riboflavin
Element B2) 0.15%, pyridoxine hydrochloride (vitamin B6) 1.2%, cobalamin (vitamin B12) 3.2%, cigarette
Amide 8.4%, folic acid 2.2%, D-VB5 calcium 2.8%, biotin 3.3%, potassium iodide 1.5%, lactose 21.45%.
Animal bifidobacteria (Bb-12) specification is 30IF, and Bifidobacterium lactis (Bi-07) specification is 300B,
It is 1 × 10 that probiotic bacteria animal bifidobacteria (Bb-12) and Bifidobacterium lactis (Bi-07) add total amount7cfu/g。
The preparation method of the present embodiment is same as in Example 1, prepares formula milk, testing result such as table 1 below institute
Show.
Table 1: testing result, product nutrient composition content:
Test basis is GB10765-2010 " food security standard infant formula ", and with reference to this standard,
The formula milk nutrient composition content result prepared from above-mentioned table one illustrated embodiment 1, embodiment 2, this
The formula milk that inventive embodiments 1, embodiment 2 prepare all complies with the national standard requirements.
Water activity and bifidobacteria viable bacteria fungal counting:
Detection sample: embodiment 1, embodiment 2, comparative example (commercial prebiotics probiotic bacteria milk powder)
Detection method: GB/T 4789.35-2010
Testing result: such as table 2 below
Table 2 water activity and bifidobacteria viable bacteria fungal counting result
| Color | Bacillus bifidus number cfu/g | Water activity | |
| Embodiment 1 | Milk yellow | 2.30E+7 | 0.127Aw |
| Embodiment 2 | Milk yellow | 2.19E+7 | 0.108Aw |
| Comparative example | Milk yellow | 1.14E+7 | 0.206Aw |
Research shows, compared with existing milk powder, the simulation breast milk baby formula milk powder of the present invention has higher
Active bacteria number and lower low moisture activity, can better ensure that probiotic stability.
Sensory evaluation: Example 1 and Example 2 of the present invention carries out sense organ experiment, evaluation criterion is according to " China
Dairy processing industry industry standard RHB 204-2004 " infant formula sense organ criticism detailed rules and regulations.
15.1 grams of milk powder of formula milk that Example 1,2 prepares respectively, add 90 milliliters of water, are configured to
The milk of about 100 milliliters, energy contained under instant state is about 290kJ/100mL.It is observed that and understand this
The formula milk color and luster that bright embodiment 1,2 prepares is homogeneous, in milk yellow, milk yellow light yellow, shallow, deep yellow
The colors such as color, glossy；Granule is uniform, moderate, loose, good fluidity, and when being dissolved in water, sinking time is little
In 10s, brew is good；Producing without agglomerate, milk has the distinctive fragrance of breast milk, and abnormal smells from the patient is natural.
Tracking of products is evaluated:
One, testing program
According to " baby formula milk powder nutrition, safe tracking evaluation scheme ", to embodiment of the present invention 1-2 system
The baby formula milk powder milk powder commercialized product of the simulation breast milk obtained is paid a return visit, its trophism of tracking evaluation, peace
Full property and product sensory characteristic, wherein babies ' formula milk powder, bigger babies ' formula milk powder, baby formulas milk powder return
Visit number is respectively no less than 5 people.
Two, result and conclusion are paid a return visit
It is as follows that result paid a return visit by inventive formulation milk powder:
Table 3 is simulated the baby formula milk powder of breast milk and is paid a return visit result
From statistical result in table 3: during the baby formula milk powder of edible simulation breast milk, baby's height
Grow normal with body weight, there is good resistance；All do not occur getting angry, constipation, allergy/eczema etc. bad
Reaction, only 1 mild diarrhea paying a return visit object appearance the most once, and 1,2 days just get well,
Getting rid of the impact of milk powder, therefore milk powder has good trophism and safety；The structural state of milk powder is normal,
Growing abnormal smells from the patient is normal Olibanum, but has 1 return visit object the most improper, so that there is brew because reconstituting method
The phenomenon of difference, therefore brew is normal, acceptance level is normal or fine, has good product sensory characteristic.
Table 4 is simulated the baby formula milk powder of breast milk and is paid a return visit result
From statistical result in table 4: during the baby formula milk powder of edible simulation breast milk, bigger baby
Height and body weight are grown normal, have good resistance；All do not occur getting angry, the untoward reaction such as constipation, have
Pay a return visit object mild diarrhea once in a while, pay a return visit object slight allergy once in a while, but the most quickly get well for 1 for 1,
Therefore get rid of the impact of milk powder, therefore milk powder has good trophism and safety；Milk powder structural state is normal,
Growing the normal Olibanum of abnormal smells from the patient, brew is normal or very well, acceptance level is fine, has good product sensory characteristic.
From statistical result in table 5: during the baby formula milk powder of edible simulation breast milk, child's height
Grow normal with body weight, there is good resistance；The untoward reaction such as allergy, eczema does not all occur, has 1
Pay a return visit object and mild diarrhea occurs when turning milk, pay a return visit object for 1 and slight constipation occurs once in a while, therefore get rid of milk powder
Impact, therefore milk powder has good trophism and safety；The structural state of milk powder is normal, is just growing abnormal smells from the patient
Often Olibanum, brew is normal or very well, acceptance level is normal or fine, has good product sensory characteristic.
Table 5 is simulated the baby formula milk powder of breast milk and is paid a return visit result
Conclusion: in sum, the present invention simulate breast milk baby formula milk powder milk powder listing after eating condition good
Good, there is good trophism, safety and product sensory characteristic.
Being described in detail the specific embodiment of the present invention above, but it is intended only as example, the present invention is also
It is not restricted to particular embodiments described above.To those skilled in the art, any the present invention is carried out
Equivalent modifications and substitute the most all among scope of the invention.Therefore, without departing from the spirit of the present invention and model
Enclose lower made impartial conversion and amendment, all should contain within the scope of the invention.
Claims (10)
1. the baby formula milk powder simulating breast milk, it is characterised in that by weight percentage, by following former
Material component is formulated: skimmed milk powder 10～40%, desalted whey powder 25～45%, concentrated whey protein powder 1.0～
8.0%, 1,3-bis-oleic acid 2-palmitic acid three ester (OPO structured lipid) 5～20%, vegetable oil 5～20%,
Lactose 5～20%, phosphatidase 0～0.5%, calcium carbonate 0.01～0.5%, compounding mineral substance premix 0.05～0.95%,
Compounding vitamin premix 0.01～0.12%, oligomeric galactose 0.1～5.0%, oligofructose 0.1～5.0%,
Animal bifidobacteria (Bb-12) 0～0.1%, Bifidobacterium lactis (Bi-07) 0～0.1%, two dodecahexaenes
Acid 0～0.14%, eicosatetraenoic acid 0～0.18%, choline 0～0.05%, nucleotide 0～0.06%, leaf are yellow
Element 0～0.0004%, L-carnitine 0.01～0.1%, taurine 0～0.07%, inositol 0.01～0.2%, L-
Sodium ascorbate 0.03～0.12%；
Described compounding mineral substance premix by mass percentage, including following raw material components: potassium chloride 5～
33%, sodium chloride 6～18%, copper sulfate 0.01～0.50%, magnesium sulfate 5～15%, ferrous sulfate 10～45%,
Zinc sulfate 0.5～8.0%, manganese sulfate 0.1～1.0%, sodium selenite 0.1～5.0%, sodium citrate 10～21%,
Lactose 10～25%；
Described compounding vitamin premix by mass percentage, including following raw material components: retinol acetate (dimension
Raw element A) 5～18%, cholecalciferol (vitamin D3) 3～12%, dl-α-tocopheryl acetate (vitamin E)
27～40%, phytonadione (vitamin K) 0.5～5.0%, thiamine nitrate (vitamin B1) 0.5～
4.0%, riboflavin (vitamin B2) 0.05～3.00%, pyridoxine hydrochloride (vitamin B6) 0.5～3.0%,
Cobalamin (vitamin B12) 0.5～5.0%, nicotiamide 4～12%, folic acid 0.5～5.0%, D-VB5 calcium
0.5～5.0%, biotin 0.5～5.0%, potassium iodide 0.5～5.0%, lactose 15～30%；
Described animal bifidobacteria (Bb-12) specification is 30IF (30 × 108Cfu/g), Bifidobacterium lactis (Bi-07)
Specification is 300B (300 × 108Cfu/g), described animal bifidobacteria (Bb-12) and Bifidobacterium lactis (Bi-07)
Interpolation total amount be 0.5 × 107～3 × 107cfu/g。
The baby formula milk powder of simulation breast milk the most according to claim 1, it is characterised in that by weight hundred
Proportion by subtraction meter, formulated by following raw material components: skimmed milk powder 15～35%, desalted whey powder 30～45%,
Concentrated whey protein powder 1.0～5.0%, 1,3-bis-oleic acid 2-palmitic acid three ester (OPO structured lipid) 7～
13%, vegetable oil 8～15%, lactose 8～15%, phosphatidase 0 .2～0.4%, calcium carbonate 0.1～0.35%, compounding
Mineral substance premix 0.1～0.8%, compounding vitamin premix 0.05～0.10%, oligomeric galactose 0.5～
2%, oligofructose 0.2～2%, animal bifidobacteria (Bb-12) 0.001～0.05%, Bifidobacterium lactis (Bi-07)
0.001～0.05%, docosahexenoic acid 0.01～0.1%, eicosatetraenoic acid 0.05～0.1%, choline
0.02～0.04%, nucleotide 0～0.03%, phylloxanthin 0.0001～0.0003%, L-carnitine 0～0.02%,
Taurine 0.01～0.04%, inositol 0～0.1%, L-AA sodium 0.04～0.11%.
The baby formula milk powder of simulation breast milk the most according to claim 1, it is characterised in that by weight hundred
Proportion by subtraction meter, formulated by following raw material components: skimmed milk powder 18%, desalted whey powder 40%, condensed whey
Egg albumen powder 1.5%, vegetable oil 14%, 1,3-bis-oleic acid 2-palmitic acid three ester (OPO structured lipid) 12%,
Lactose 11.7568%, phosphatidase 0 .15%, calcium carbonate 0.3%, compounding mineral substance premix 0.7%, compounding dimension are raw
Element premix material 0.07%, oligomeric galactose 0.8%, oligofructose 0.4%, animal bifidobacteria (Bb-12) 0.003%,
Bifidobacterium lactis (Bi-07) 0.005%, docosahexenoic acid 0.03%, eicosatetraenoic acid 0.06%, gallbladder
Alkali 0.06%, inositol 0.03%, nucleotide 0.03%, phylloxanthin 0.0002%, L-carnitine 0.01%, cattle sulphur
Acid 0.035%, L-AA sodium 0.06%.
The baby formula milk powder of simulation breast milk the most according to claim 1, it is characterised in that by quality hundred
Proportion by subtraction meter, described compounding mineral substance premix includes following raw material components: potassium chloride 26%, sodium chloride 12.5%,
Copper sulfate 0.12%, magnesium sulfate 10.5%, ferrous sulfate 13.5%, zinc sulfate 1.78%, manganese sulfate 0.15%,
Sodium selenite 0.55%, sodium citrate 14.4%, lactose 19.5%.
The baby formula milk powder of simulation breast milk the most according to claim 1, it is characterised in that by quality hundred
Proportion by subtraction meter, described compounding vitamin premix includes following raw material components: retinol acetate (vitamin A) 9.8%,
Cholecalciferol (vitamin D3) 6.5%, dl-α-tocopheryl acetate (vitamin E) 34.5%, phytonadione
(vitamin K) 2.2%, thiamine nitrate (vitamin B1) 0.95%, riboflavin (vitamin B2) 0.23%,
Pyridoxine hydrochloride (vitamin B6) 0.91%, cobalamin (vitamin B12) 2.91%, nicotiamide 8.0%,
Folic acid 2.2%, D-VB5 calcium 2.7%, biotin 2.8%, potassium iodide 2.0%, lactose 24.3%.
The baby formula milk powder of simulation breast milk the most according to claim 1, it is characterised in that described plant
Oil mixes according to 1.2:1 ratio for mixed vegetable oil and OPO Structure grease, and wherein mixed vegetable oil is by greatly
Oleum Glycines, high oleic sunflower oil, Semen Maydis oil, Petiolus Trachycarpi oil and Oleum Cocois are by weight 1:(0.5-1.2):
(1-1.6): (0.3-0.8): (1.5-2.3) mixes.
The baby formula milk powder of simulation breast milk the most according to claim 1, it is characterised in that described animal
It is 1 × 10 that bacillus bifidus (Bb-12) and Bifidobacterium lactis (Bi-07) add total amount7cfu/g。
8. a preparation method for the baby formula milk powder of the simulation breast milk as described in claim 1-7, its feature
It is, comprises the following steps:
Step 1, one-level batch mixing: by skimmed milk powder, desalted whey powder, concentrated whey protein powder, vegetable oil,
Lactose, phospholipid and calcium carbonate use the pure water mixed dissolution of 50～70 DEG C, are sufficiently stirred for；
Step 2, two grades of batch mixings: by compounding mineral substance premix, compounding vitamin premix respectively each special
By 20 times amount 30～the dissolved in purified water of 40 DEG C in container, substep add step 1 to) batch mixing in fill
Divide mixing, compounding mineral and compounding vitamin to add incorporation time and answer >=10min；
Step 3, homogenizing: by step 2) dissolve the material mixed and carry out homogenizing, homogenization pressure be 20～
22Mpa；
Step 4, pre-sterilizing: by step 3) material after homogenizing carries out pre-sterilizing, sterilization temperature 80～90 DEG C,
Sterilizing time 16s, cools down, keeps in, temporary temperature 8～15 DEG C, temporary storage time≤4h；
Step 5, sterilization concentrates: by step 4) temporary material sends into vaporization chamber and carries out sterilization and concentrate, sterilization
Temperature 87～90 DEG C, sterilizing time 24s, an effect evaporating temperature 62～72 DEG C, two effect evaporating temperatures 46～56 DEG C,
Evaporating pressure-0.086～-0.095Mpa, sterilization pressure 0.05～0.02Mpa；Discharge concentration 16.0～21.0 ° of Be；
Step 6, be dried: by step 5) concentrate after material send into drying tower through high-pressure pump, process conditions are:
Inlet temperature 145～175 DEG C, temperature of outgoing air 65～92 DEG C, negative pressure (-0.5～-4.0) × 100pa in tower, fluidisation
Bed negative pressure: (-0.5～-3.5) × 100pa, one section of temperature 30～85 DEG C, two-stage nitration temperature 5～55 DEG C, three sections of temperature
5～35 DEG C, four sections of temperature 5～30 DEG C, high-pressure pump pressure 15～30Mpa is spray-dried；And by stream
Change bed and carry out redrying powder delivery, powder delivery temperature≤38 DEG C, moisture≤4.0%, obtain original washing powder；
Step 7, premix: by animal bifidobacteria (Bb-12), Bifidobacterium lactis (Bi-07), oligomeric half
Lactose, oligofructose, docosahexenoic acid, eicosatetraenoic acid, choline, nucleotide, phylloxanthin, a left side
Rotation carnitine, taurine, inositol, L-AA sodium premix respectively according to addition；
Step 8, mixing: by original washing powder and step 7) premix material mixes according to formula proportion, obtains finished powder；
Step 9, packaging, detection, warehouse-in.
The preparation method of the baby formula milk powder of simulation breast milk the most according to claim 8, it is characterised in that
Described step 2) in, when dissolving compounding mineral substance premix and compounding vitamin premix, first dissolve compounding ore deposit
Material premix material, after 10min, re-dissolved compounds vitamin premix.
The preparation method of the baby formula milk powder of simulation breast milk the most according to claim 8, it is characterised in that
Step 7) in, described animal bifidobacteria (Bb-12), Bifidobacterium lactis (Bi-07), oligomeric galactose,
Oligofructose, docosahexenoic acid, eicosatetraenoic acid, choline, nucleotide, phylloxanthin, L-carnitine,
Taurine, inositol, L-AA sodium need, through expanding dilution, to expand dilution and use HS-10 tri-before premix material
Dimension movement mixer, motion frequency is 35HZ, and incorporation time is 30s.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610143847.4A CN105746728A (en) | 2016-03-14 | 2016-03-14 | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610143847.4A CN105746728A (en) | 2016-03-14 | 2016-03-14 | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105746728A true CN105746728A (en) | 2016-07-13 |
Family
ID=56332029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610143847.4A Pending CN105746728A (en) | 2016-03-14 | 2016-03-14 | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105746728A (en) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106343029A (en) * | 2016-08-26 | 2017-01-25 | 黑龙江飞鹤乳业有限公司 | Infant formula for improving intestinal absorption and comfort and preparing method thereof |
| CN107897380A (en) * | 2017-12-12 | 2018-04-13 | 河北三元食品有限公司 | A kind of close to breast milk and have the function of prebiotic babies ' formula milk powder of enteron aisle and preparation method thereof |
| CN108174921A (en) * | 2018-02-08 | 2018-06-19 | 呼伦贝尔双娃乳业有限公司 | A kind of organic babies ' formula milk powder |
| CN108294112A (en) * | 2018-01-12 | 2018-07-20 | 雅士利国际婴幼儿营养品有限公司 | Optimize the babies ' formula milk powder and preparation method thereof of protein and amino acid pattern |
| CN108522655A (en) * | 2018-04-13 | 2018-09-14 | 内蒙古欧世蒙牛乳制品有限责任公司 | The baby milk and preparation method of micro functional active components in a kind of across-the-board regulation formula |
| CN108813262A (en) * | 2018-07-02 | 2018-11-16 | 杭州相生相成科技有限公司 | A kind of compound probiotic solid beverage containing DHA algal oil |
| CN108991503A (en) * | 2018-07-11 | 2018-12-14 | 谢碧平 | A kind of baby's special formulation powder rich in microelement |
| CN109105495A (en) * | 2018-08-15 | 2019-01-01 | 西安安诺乳业有限公司 | Baby formula milk powder and preparation method thereof containing choline chloride and L-carnitine |
| CN109122902A (en) * | 2018-08-15 | 2019-01-04 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing lutein |
| CN109221443A (en) * | 2018-08-15 | 2019-01-18 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing inositol and taurine |
| CN110074209A (en) * | 2019-05-16 | 2019-08-02 | 福建农林大学 | A kind of baby formula milk powder and preparation method thereof containing human milk oligosaccharides and lactoferrin |
| CN110100905A (en) * | 2019-05-17 | 2019-08-09 | 福建农林大学 | A kind of baby formula milk powder containing human milk oligosaccharides and OPO structured lipid |
| CN110693004A (en) * | 2018-07-10 | 2020-01-17 | 杨国民 | Amino acid formula powder and preparation method thereof |
| CN110692741A (en) * | 2019-11-12 | 2020-01-17 | 湖南贝恩叮当猫婴童用品有限公司 | Formula milk powder for promoting bone growth and preparation method thereof |
| CN110742130A (en) * | 2019-11-14 | 2020-02-04 | 东北农业大学 | Infant formula goat milk powder added with liposome simulating breast milk fat structure and preparation method thereof |
| CN111011522A (en) * | 2020-02-27 | 2020-04-17 | 青岛索康食品有限公司 | Children formula milk powder capable of improving immunity and preparation method thereof |
| CN111264633A (en) * | 2020-02-27 | 2020-06-12 | 青岛索康食品有限公司 | Children formula milk powder beneficial to intestinal health and preparation method thereof |
| CN112136895A (en) * | 2020-10-10 | 2020-12-29 | 西安朵拉倍拉生物科技有限公司 | Lactobacillus formula goat milk powder and preparation method thereof |
| CN112602783A (en) * | 2020-12-29 | 2021-04-06 | 光明乳业股份有限公司 | Infant formula milk powder and preparation method thereof |
| CN112998080A (en) * | 2021-03-16 | 2021-06-22 | 北安宜品努卡乳业有限公司 | Infant formula milk powder added with yolk phospholipid, soybean phospholipid and milk phospholipid |
| CN115005283A (en) * | 2022-05-17 | 2022-09-06 | 广州迪卡德营养科技有限公司 | Formula milk powder for promoting intelligence and bone development and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103621633A (en) * | 2013-12-05 | 2014-03-12 | 刘保惠 | Infant series yak milk formula milk powder and preparation method thereof |
| CN104757123A (en) * | 2015-04-03 | 2015-07-08 | 长沙素加营养品有限公司 | Full dry-mixing infant formula milk powder and preparation method of full dry-mixing infant formula milk powder |
-
2016
- 2016-03-14 CN CN201610143847.4A patent/CN105746728A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103621633A (en) * | 2013-12-05 | 2014-03-12 | 刘保惠 | Infant series yak milk formula milk powder and preparation method thereof |
| CN104757123A (en) * | 2015-04-03 | 2015-07-08 | 长沙素加营养品有限公司 | Full dry-mixing infant formula milk powder and preparation method of full dry-mixing infant formula milk powder |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106343029A (en) * | 2016-08-26 | 2017-01-25 | 黑龙江飞鹤乳业有限公司 | Infant formula for improving intestinal absorption and comfort and preparing method thereof |
| CN107897380A (en) * | 2017-12-12 | 2018-04-13 | 河北三元食品有限公司 | A kind of close to breast milk and have the function of prebiotic babies ' formula milk powder of enteron aisle and preparation method thereof |
| CN107897380B (en) * | 2017-12-12 | 2021-06-22 | 河北三元食品有限公司 | Infant formula milk powder similar to breast milk and having intestinal tract benefiting function and preparation method thereof |
| CN108294112A (en) * | 2018-01-12 | 2018-07-20 | 雅士利国际婴幼儿营养品有限公司 | Optimize the babies ' formula milk powder and preparation method thereof of protein and amino acid pattern |
| CN108294112B (en) * | 2018-01-12 | 2021-08-06 | 雅士利国际婴幼儿营养品有限公司 | Infant formula with optimized protein and amino acid patterns and preparation method thereof |
| CN108174921A (en) * | 2018-02-08 | 2018-06-19 | 呼伦贝尔双娃乳业有限公司 | A kind of organic babies ' formula milk powder |
| CN108522655A (en) * | 2018-04-13 | 2018-09-14 | 内蒙古欧世蒙牛乳制品有限责任公司 | The baby milk and preparation method of micro functional active components in a kind of across-the-board regulation formula |
| CN108813262A (en) * | 2018-07-02 | 2018-11-16 | 杭州相生相成科技有限公司 | A kind of compound probiotic solid beverage containing DHA algal oil |
| CN110693004A (en) * | 2018-07-10 | 2020-01-17 | 杨国民 | Amino acid formula powder and preparation method thereof |
| CN108991503A (en) * | 2018-07-11 | 2018-12-14 | 谢碧平 | A kind of baby's special formulation powder rich in microelement |
| CN109221443A (en) * | 2018-08-15 | 2019-01-18 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing inositol and taurine |
| CN109122902A (en) * | 2018-08-15 | 2019-01-04 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing lutein |
| CN109105495A (en) * | 2018-08-15 | 2019-01-01 | 西安安诺乳业有限公司 | Baby formula milk powder and preparation method thereof containing choline chloride and L-carnitine |
| CN110074209A (en) * | 2019-05-16 | 2019-08-02 | 福建农林大学 | A kind of baby formula milk powder and preparation method thereof containing human milk oligosaccharides and lactoferrin |
| CN110100905A (en) * | 2019-05-17 | 2019-08-09 | 福建农林大学 | A kind of baby formula milk powder containing human milk oligosaccharides and OPO structured lipid |
| CN110692741A (en) * | 2019-11-12 | 2020-01-17 | 湖南贝恩叮当猫婴童用品有限公司 | Formula milk powder for promoting bone growth and preparation method thereof |
| CN110742130A (en) * | 2019-11-14 | 2020-02-04 | 东北农业大学 | Infant formula goat milk powder added with liposome simulating breast milk fat structure and preparation method thereof |
| CN111011522A (en) * | 2020-02-27 | 2020-04-17 | 青岛索康食品有限公司 | Children formula milk powder capable of improving immunity and preparation method thereof |
| CN111264633A (en) * | 2020-02-27 | 2020-06-12 | 青岛索康食品有限公司 | Children formula milk powder beneficial to intestinal health and preparation method thereof |
| CN112136895A (en) * | 2020-10-10 | 2020-12-29 | 西安朵拉倍拉生物科技有限公司 | Lactobacillus formula goat milk powder and preparation method thereof |
| CN112602783A (en) * | 2020-12-29 | 2021-04-06 | 光明乳业股份有限公司 | Infant formula milk powder and preparation method thereof |
| CN112998080A (en) * | 2021-03-16 | 2021-06-22 | 北安宜品努卡乳业有限公司 | Infant formula milk powder added with yolk phospholipid, soybean phospholipid and milk phospholipid |
| CN115005283A (en) * | 2022-05-17 | 2022-09-06 | 广州迪卡德营养科技有限公司 | Formula milk powder for promoting intelligence and bone development and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105746728A (en) | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder | |
| CN108029768A (en) | A kind of baby formula milk powder containing lactoferrin and probiotics and preparation method thereof | |
| CN105724584A (en) | Infant formula milk powder with prebiotics and probiotics and method for preparing infant formula milk powder | |
| CN102283288B (en) | Infant formula goat milk powder added with structural grease and preparation method thereof | |
| AU2010203123B2 (en) | Infant formula containing nucleotides | |
| CN109452370A (en) | A kind of student's formula milk and its preparation process | |
| RU2749672C2 (en) | Composition of lipids for use in infants and young children, promoting intestinal comfort and optimal absorption of fat and calcium | |
| CN110100905A (en) | A kind of baby formula milk powder containing human milk oligosaccharides and OPO structured lipid | |
| CN111227045B (en) | Application of dairy product in promoting growth of length of mammal | |
| CN106605709B (en) | Liquid milk suitable for children of 3-6 years old and preparation method thereof | |
| CN108013143A (en) | One kind strengthens the formula milk of 12 ~ 36 months infant's gastrointestinal functions | |
| CN105994680A (en) | Infant formula goat milk powder and preparation method thereof | |
| CN106259938A (en) | Breast milk 0-12 month babies ' formula milk powder containing nucleotide and OPO structured lipid and preparation method thereof | |
| CN111345351A (en) | Novel milk powder and its preparation method | |
| TW201444480A (en) | Nutritional compositions containing structured fat globules and uses thereof | |
| CN111067104A (en) | Composite probiotic infant formula milk powder and preparation method thereof | |
| EP2879508B1 (en) | Infant formula or growing up milk | |
| CN112998080A (en) | Infant formula milk powder added with yolk phospholipid, soybean phospholipid and milk phospholipid | |
| CN105076417A (en) | Intestine protective formula milk powder and preparation method thereof | |
| RU2703177C2 (en) | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid | |
| WO2004095944A2 (en) | High lactose infant nutrition formula | |
| CN104185428A (en) | Methods for reducing microbial contamination of dryblended powdered nutritional compositions | |
| CN107105739A (en) | Infant nutrition containing aminosal and palmitic acid | |
| US20140170265A1 (en) | Infant formula cubes | |
| JP6019577B2 (en) | Method for producing liquid emulsion composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160713 |
|
| RJ01 | Rejection of invention patent application after publication |